MAPT and Alzheimer disease: In addition to the aforementioned oral infection profile that reflects the degree of stroke risk, it has been shown that salivary Aβ42, tau proteins, certain metabolites, and oral microbiota have predictive biomarker value for the diagnosis of Alzheimer’s disease (AD) [68].